Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and is projected to attain a value of USD 28.96 Billion by 2035 at a CAGR of 11.

The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

An Ohio State spinoff has raised $5 million to speed already fast-growing sales of its AI-powered software for heart surgeons ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Notably, new permanent pacemakers (PPMs) stayed at 17.8% for both Navitors, but in those without baseline conduction defects, the figure dropped to 12.3% for Navitor Vision versus ...

Transcatheter aortic valve implantation (TAVI) has transformed the treatment of aortic stenosis.1 A series of strategy trials comparing TAVI with surgical aortic valve replacement established TAVI as ...

With the expansion of TAVI into low-risk patients, heart teams are encountering bicuspid anatomy more frequently. Bicuspid anatomy results in earlier valve degeneration, and the mean age of these ...

Objective In patients with bicuspid aortic valve (BAV), coronary anatomy is variable. High take-off coronary arteries have been described, but data are scarce, especially when associated with complex ...

Divided into four sections—the aortic root, ascending aorta, aortic arch, and descending aorta—it ensures blood reaches areas like the arms, legs, brain, and abdominal organs. Signs of a problem with ...

Introduction The application of the Heart Team to facilitate transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis is now established in routine clinical practice with ...